Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESUS: Sirolimus in Advanced Chronic Liver Disease
NCT05663944Phase 2Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Jul 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in chronic liver disease (CLD), sponsored by Nottingham University Hospitals. Started Jul 2022; status: completed.
02
Drugs
sirolimus
03
Conditions
chronic liver disease (CLD)
Beyond the preview
Go deeper on NCT05663944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05663944.